Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Open access

 

Labco IPO values EBITDA at 9-10 times

Pan-European lab group Labco hopes to raise €320m gross of new money through an IPO which will also see existing shareholders sell between €120m and €238m of shares. The IPO means an enterprise value of €1.26bn to €1.4bn, valuing forecast 2015 EBITDA at just ten times. Bankers and exiting shareholders have their fingers and legs firmly crossed – Labco’s public offering closes on May 11, the EU deadline given to Greece. We look at the valuation and what Labco plans to do with the money.

Myanmar is sweet spot for labs

Eric Souetre, executive chairman of private equity pledge fund CareVentures, identified Myanmar as the next up-and-coming Asian country to invest in at the Healthcare Europa 2015 conference in London this week.

Younger generation buying into dentistry brands

Dentistry is a consumer brand; and in this digital age marketing and customer communication is the same for dentists as it is for retailers and supermarkets says Justin Ash, CEO of Oasis Healthcare at Healthcare Europa 2015. He says there are clear differences between how the under 30s and the over 50s relate to dentistry brands.

Czech nursing home sector set to expand

Anavita, one of the three largest nursing home groups in the Czech Republic, plans to grow from six homes with 800 beds to 10 homes in the next 2 years. We caught up with David Volny, the co-owner of Anavita at the annual Healthcare Europa conference and talked to him about the Czech private nursing home sector.

Interview: Dr Nata Menabde, WHO Representative to India

A scheme that gives 37m poor Indians access to acute care for a very low price and engages with the private sector sounds too good to be true. We talk to Dr Menabde about the Rashtriya Swasthya Bima Yojana (RSBY), a nationwide secondary care insurance scheme launched by India in 2008. Has the RSBY been a success? What is its future? And what does it mean for the future of healthcare in India and other Emerging Markets?

Chinese private hospitals face huge problems

We talk to a seasoned healthcare consultant just back from China on the three reasons why investing in Chinese hospitals may not be the blue-eyed bargain you might expect.

Find Us